• Something wrong with this record ?

Paraneoplastic or not? Sirtuin 2 in anti-N-methyl-d-aspartate receptor encephalitis

O. Stevens-Jones, H. Mojzisova, M. Elisak, R. Constantinescu, J. Hanzalova, M. Axelsson, D. Krysl

. 2023 ; 30 (10) : 3228-3235. [pub] 20230802

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23016121

BACKGROUND AND PURPOSE: N-methyl-d-aspartate receptor (NMDAR) and leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis are important types of autoimmune encephalitis (AE) with significant morbidity. In this study, we used a proteomic approach in search of novel clinically relevant biomarkers in these types of encephalitides. METHODS: Swedish and Czech tertiary neuroimmunology centers collaborated in this retrospective exploratory study. Fifty-eight cerebrospinal fluid (CSF) samples of 28 patients with AE (14 definite NMDAR, 14 with definite LGI1 encephalitis) and 30 controls were included. CSF samples were analyzed using proximity extension assay technology (Olink Target 96 Inflammation panel). For each CSF sample, 92 proteins were measured. Clinical variables were retrospectively collected, and correlations with protein levels were statistically analyzed. RESULTS: Patients and controls differed significantly in the following 18 biomarkers: TNFRSF9, TNFRSF12, TNFRSF14, TNFβ, TNFα, IL7, IL10, IL12B, IFNγ, CD5, CD6, CASP8, MMP1, CXCL8, CXCL10, CXCL11, IL20RA, and sirtuin 2 (SIRT2). In LGI1 encephalitis, no clinically useful association was found between biomarkers and clinical variables. In the NMDAR encephalitis group, SIRT2, TNFβ, and CD5 were significantly associated with ovarian teratoma. For SIRT2, this was true even for the first patients' CSF sample (SIRT2 without vs. with tumor, mean ± SD = 2.2 ± 0.29 vs. 2.88 ± 0.48; p = 0.007, 95% confidence interval = -1.15 to -0.22; r statistic in point-biserial correlation (rpb) = 0.66, p = 0.011). SIRT2 was positively correlated with age (rpb = 0.39, p = 0.018) and total hospital days (r = 0.55, p = <0.001). CONCLUSIONS: SIRT2 should be investigated as a biomarker of paraneoplastic etiology in NMDAR encephalitis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016121
003      
CZ-PrNML
005      
20231026110356.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.15987 $2 doi
035    __
$a (PubMed)37483157
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Stevens-Jones, Oskar $u Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden $u Institute of Neuroscience and Physiology, Sahlgrenska Akademin, Gothenburg University, Gothenburg, Sweden $1 https://orcid.org/0000000196110519
245    10
$a Paraneoplastic or not? Sirtuin 2 in anti-N-methyl-d-aspartate receptor encephalitis / $c O. Stevens-Jones, H. Mojzisova, M. Elisak, R. Constantinescu, J. Hanzalova, M. Axelsson, D. Krysl
520    9_
$a BACKGROUND AND PURPOSE: N-methyl-d-aspartate receptor (NMDAR) and leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis are important types of autoimmune encephalitis (AE) with significant morbidity. In this study, we used a proteomic approach in search of novel clinically relevant biomarkers in these types of encephalitides. METHODS: Swedish and Czech tertiary neuroimmunology centers collaborated in this retrospective exploratory study. Fifty-eight cerebrospinal fluid (CSF) samples of 28 patients with AE (14 definite NMDAR, 14 with definite LGI1 encephalitis) and 30 controls were included. CSF samples were analyzed using proximity extension assay technology (Olink Target 96 Inflammation panel). For each CSF sample, 92 proteins were measured. Clinical variables were retrospectively collected, and correlations with protein levels were statistically analyzed. RESULTS: Patients and controls differed significantly in the following 18 biomarkers: TNFRSF9, TNFRSF12, TNFRSF14, TNFβ, TNFα, IL7, IL10, IL12B, IFNγ, CD5, CD6, CASP8, MMP1, CXCL8, CXCL10, CXCL11, IL20RA, and sirtuin 2 (SIRT2). In LGI1 encephalitis, no clinically useful association was found between biomarkers and clinical variables. In the NMDAR encephalitis group, SIRT2, TNFβ, and CD5 were significantly associated with ovarian teratoma. For SIRT2, this was true even for the first patients' CSF sample (SIRT2 without vs. with tumor, mean ± SD = 2.2 ± 0.29 vs. 2.88 ± 0.48; p = 0.007, 95% confidence interval = -1.15 to -0.22; r statistic in point-biserial correlation (rpb) = 0.66, p = 0.011). SIRT2 was positively correlated with age (rpb = 0.39, p = 0.018) and total hospital days (r = 0.55, p = <0.001). CONCLUSIONS: SIRT2 should be investigated as a biomarker of paraneoplastic etiology in NMDAR encephalitis.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    12
$a encefalitida s protilátkami proti NMDA receptorům $x mozkomíšní mok $7 D060426
650    _2
$a autoprotilátky $7 D001323
650    _2
$a biologické markery $x mozkomíšní mok $7 D015415
650    _2
$a proteomika $7 D040901
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a sirtuin 2 $7 D056565
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mojzisova, Hana $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000283132687
700    1_
$a Elisak, Martin $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Constantinescu, Radu $u Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden $u Institute of Neuroscience and Physiology, Sahlgrenska Akademin, Gothenburg University, Gothenburg, Sweden
700    1_
$a Hanzalova, Jitka $u Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Axelsson, Markus $u Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden $u Institute of Neuroscience and Physiology, Sahlgrenska Akademin, Gothenburg University, Gothenburg, Sweden $1 https://orcid.org/0000000320364007
700    1_
$a Krysl, David $u Institute of Neuroscience and Physiology, Sahlgrenska Akademin, Gothenburg University, Gothenburg, Sweden $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $u Department of Clinical Neurophysiology, Sahlgrenska University Hospital, Gothenburg, Sweden $1 https://orcid.org/0000000177806617
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 30, č. 10 (2023), s. 3228-3235
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37483157 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110350 $b ABA008
999    __
$a ok $b bmc $g 1999940 $s 1202483
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 30 $c 10 $d 3228-3235 $e 20230802 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Archiving options